Fitzsimon_menu

Find out what's happening on campus and across the industry.

Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.

Change Please Brings Coffee with a Cause to Fitzsimons Innovation Community
Blog | Oct 31, 2024

Change Please Brings Coffee with a Cause to Fitzsimons Innovation Community

Here on the Fitzsimons Innovation Community campus, life sciences professionals thrive on collaboration, innovation, and breakthroughs in patient care. Another thing they thrive on? Caffeine. One of our newest Community members brings caffeine to spare, but they also bring compassion, forward thinking, and a business model that drives meaningful social change—one cup of coffee at a time.

Lohocla Research Corp. Recognized as 2024 Colorado Inno Award Winner
News | Oct 28, 2024

Lohocla Research Corp. Recognized as 2024 Colorado Inno Award Winner

Colorado Inno Awards has selected Lohocla Research Corp as one of its 10 trailblazers making waves in the Colorado innovation ecosystem. Lohocla received FDA clearance in March for the first-in-human trials of a drug, Nezavist, intended to treat alcohol use disorder and craving. The company also received similar FDA clearance in October 2023 to move forward with Phase 1 trials of another drug it developed, Kindolor, to treat chronic pain.

Aurora mayor eyes redevelopment as catalyst to city's success
News | Oct 28, 2024

Aurora mayor eyes redevelopment as catalyst to city's success

Mike Coffman, City of Aurora Mayor and Fitzsimons Innovation Community Board Member, gave his annual State of the City address last week with a focus on maximizing the opportunity that exists with ongoing development of the CU Anschutz Medical Campus and the Fitzsimons Innovation Community.

Steve VanNurden Joins Denver Dealmakers Hall of Fame
News | Oct 28, 2024

Steve VanNurden Joins Denver Dealmakers Hall of Fame

Steve VanNurden, Fitzsimons Innovation Community President and CEO, was inducted into the Denver Dealmakers Hall of Fame, recognizing a class of dealmakers that has made an often-groundbreaking impact on their organizations, industries, and the region over the course of decades in business.

Here's How Denver Stacks up at Landing Company Headquarters
News | Oct 28, 2024

Here's How Denver Stacks up at Landing Company Headquarters

Metro Denver EDC hosted national site selectors to learn about Colorado’s competitive advantage. Adams County was highlighted for its opportunity to gain companies by providing data that shows how it is a more affordable community directly adjacent to the city of Denver.

OncoVerity CEO Featured in Pharmaceutical Executive’s Profiles in Medicine Series
News | Oct 04, 2024

OncoVerity CEO Featured in Pharmaceutical Executive’s Profiles in Medicine Series

With over three decades in biotech, Max Colao, CEO of OncoVerity, is at the forefront of personalized cancer treatment. In this compelling interview with Pharmaceutical Executive, Colao discusses his journey from industry giants to leading the startup OncoVerity in revolutionizing oncology care through computational biology and machine learning.

ClinImmune, RheumaGen Innovator Brian Freed Receives ASHI’s Highest Honor
News | Oct 04, 2024

ClinImmune, RheumaGen Innovator Brian Freed Receives ASHI’s Highest Honor

Brian Freed, Ph.D., Co-Founder & Chief Science Officer, RheumaGen, Executive Director, ClinImmune, and Professor of Medicine, University of Colorado will be recognized by the American Society of Histocompatibility & Immunogenetics (ASHI) with their highest honor.